Avrobio Inc reported $16.95M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akebia Therapeutics AKBA:US $ 165.6M 7.08M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Applied Genetic Technologies AGTC:US $ 19.71M 3.16M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Epizyme EPZM:US $ 40.89M 1.89M
Gilead Sciences GILD:US $ 10214M 509M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Macrogenics MGNX:US $ 69.92M 16.88M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Takeda 4502:JP Y 1644766M 128410M